Publication | Closed Access
In vivo Inhibition of Liver and Brain Monoamine Oxidase by 1-Isonicotinyl-2-Isopropyl Hydrazine.
254
Citations
0
References
1952
Year
Subcutaneous InjectionPharmacotherapyBrain Monoamine OxidaseExperimental PharmacologyLiver HomogenatesMolecular PharmacologyMedicinal Chemistry1-Isonicotinyl-2-isopropyl HydrazinePharmacological StudyVivo InhibitionPsychoactive DrugBiochemistryPharmacologyDrug-induced Liver InjuryNatural SciencesPhysiologyNeuroscienceMonoamine Oxidase ActivityMetabolismMedicineDrug DiscoveryDrug Analysis
SummaryAfter the subcutaneous injection of l-isonicotinyl-2-isopropyl hydrazine (IIH) into rats and guinea pigs, the monoamine oxidase activity of liver homogenates, liver mitochondria, and brain mitochondria is almost completely inhibited. The probable significance of such an inhibition is indicated.